Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholesterol--when is lower better?

J B Warren1

  • 1Top Flat, Mayfair Library, London, UK. john.warren@mhra.gsi.gov.uk

Clinical Pharmacology and Therapeutics
|June 1, 2007
PubMed
Summary
This summary is machine-generated.

Current lipid profile treatment guidelines may stem from misinterpretations. This study examines common data errors to clarify cholesterol management recommendations for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parent experiences of a remote patient monitoring program enabling early discharge from the neonatal intensive care unit with nasogastric tube feeding.

Journal of neonatal-perinatal medicine·2023
Same author

Hazards of perioperative β-blockers are likely to be dose related.

British journal of anaesthesia·2015
Same author

Excessive range of statin dose in Western Australian primary care.

Internal medicine journal·2015
Same author

Physical properties of K(x)Ni(2-y)Se2 single crystals.

Journal of physics. Condensed matter : an Institute of Physics journal·2013
Same author

Phase diagram of K(x)Fe(2-y)Se(2-z)S(z) and the suppression of its superconducting state by an Fe2-Se/S tetrahedron distortion.

Physical review letters·2011
Same author

Cross-shaped bandpass filters for the near- and mid-infrared wavelength regions.

Applied optics·2010
Same journal

Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi-Regional Clinical Trials and Future Pathways.

Clinical pharmacology and therapeutics·2026
Same journal

Resolving CYP2D6 Structural Complexity with Long-Read Sequencing: Implications for Tamoxifen Precision Dosing in Thai Breast Cancer Patients.

Clinical pharmacology and therapeutics·2026
Same journal

Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

Clinical pharmacology and therapeutics·2026
Same journal

Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors.

Clinical pharmacology and therapeutics·2026
Same journal

Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review.

Clinical pharmacology and therapeutics·2026
Same journal

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.

Clinical pharmacology and therapeutics·2026
See all related articles

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Medical Data Analysis

Background:

  • Lipid-lowering drug recommendations are widespread.
  • The "lower the cholesterol, the better" approach is frequently cited.
  • Potential misinterpretations of clinical data may influence current treatment enthusiasm.

Purpose of the Study:

  • To identify and analyze common misinterpretations in lipid profile data.
  • To critically evaluate the evidence supporting aggressive cholesterol reduction.
  • To provide a clearer understanding for optimal lipid management strategies.

Main Methods:

  • Review of existing clinical trial data and meta-analyses.
  • Statistical analysis to identify common data misinterpretations.

Related Experiment Videos

  • Comparative analysis of different lipid management guidelines.

    • Main Results:

    • Two prevalent misinterpretations of lipid profile data were identified.
    • These misinterpretations may artificially inflate the perceived benefits of lower cholesterol levels.
    • Current treatment recommendations might be based on flawed data analysis.

    Conclusions:

    • Re-evaluation of the data supporting "lower is better" for cholesterol is warranted.
    • Accurate interpretation of lipid profiles is crucial for effective drug recommendations.
    • Clinical practice should be informed by precise data analysis to avoid treatment errors.